DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kurikawa N, Suga M, Kuroda S, Yamada K, Ishikawa H.
An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.
Br J Pharmacol 2003;
139 (06) 1085-1094
We do not assume any responsibility for the contents of the web pages of other providers.